Novel Approaches to Cancer Immuno-Therapeutics

Dear Colleagues,

Cancer immunotherapy uses a person’s immune system to invokes its in-built potential to kill cancer cells. Over the years, checkpoint blockade immunotherapy has revolutionized the field of cancer. Several checkpoint blockade inhibitors to molecules such as PD-1 (programmed cell death 1) and CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) have been approved by the FDA for the treatment of various cancer types. However, many of these treatments have still not reached to the majority of patients, and not all types of cancers respond to them. Additionally, some patients develop immunotherapy-associated adverse events. All of this means that there is still a lot of room for improvement when it comes to these therapies, but also huge potential.

This Special Issue is focused on recent novel developments in cancer immunotherapeutics, development of new approaches to identify novel targets of immunotherapy, and recent developments in combinatorial approaches.

Dr. Youg Raj Thaker
Dr. Frank Alexander Schildberg
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.